Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
Battistella
Maxime
M
Frémont
Guillemette
G
Vignon-Pennamen
Marie-Dominique
MD
Gornet
Jean-Marc
JM
Dubertret
Louis
L
Viguier
Manuelle
M
D001549:Benzamides; D001707:Biopsy, Needle; D003875:Drug Eruptions / Q000209:etiology; D004890:Erythema / Q000139:chemically induced*; D005500:Follow-Up Studies; D005533:Foot Dermatoses / Q000139:chemically induced* / Q000473:pathology; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000473:pathology; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011706:Pyloric Antrum; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000556:secondary; D013577:Syndrome
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate